AmerisourceBergen plans to change its name to Cencora in an effort to expand outside the U.S. and beyond drug distribution, the company announced. It said: "Cencora combines resources for broader equity, sustainablity, and impact in healthcare. The name is inspired by our customers, their patients, and our 44,000+ team members across the globe who are central to everything we do." Reference Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ABC:
- AmerisourceBergen price target raised to $190 from $170 at Argus
- AmerisourceBergen price target raised to $199 from $195 at Baird
- Billionaire Leon Cooperman Says the Bear Market Is Expected to Continue in 2023 — Here Are 2 ‘Safe Haven’ Stocks That Analysts Like
- DOJ suit shouldn’t create meaningful overhang for AmerisourceBergen, says BofA
- AmerisourceBergen calls DOJ complaint ‘an attempt to shift blame’ from DEA